FOREVER MOOD

Brand	Owner (click to sort)	Address	Description
FORVR MOOD	Jacquelyn Aina	9190 West Olympic Boulevard, Suite 332 Beverly Hills CA 90212	FOREVER MOOD;FRAGRANCES, NON-MEDICATED SKIN CARE PRODUCTS; ESSENTIAL OILS; AROMATIC ESSENTIAL OILS; ESSENTIAL OILS FOR PERSONAL, AROMATHERAPY AND HOUSEHOLD USE; ETHEREAL OILS; SCENTED ROOM SPRAYS; NON-MEDICATED AROMATIC PREPARATIONS IN THE NATURE OF CREAMS, LOTIONS, BODY SPRAYS, SHOWER GEL; AROMATIC POTPOURRIS; AIR FRAGRANCE REED DIFFUSERS;
FORVR MOOD	Jacquelyn Aina	9190 West Olympic Boulevard, Suite 332 Beverly Hills CA 90212	FOREVER MOOD;CLOTHING, NAMELY, T-SHIRTS, SHIRTS, SWEATSHIRTS, HOODED SWEATSHIRTS, SWEATPANTS, JERSEYS, TANK TOPS, HALTER TOPS, TOPS AS CLOTHING, BEACHWEAR, SWIMWEAR, SOCKS, PANTS, SHORTS, SCARVES, SILK POCKET SQUARES, JACKETS, SWEATERS, SLEEPWEAR AND PAJAMAS, LEG WARMERS, KNEE WARMERS, ARM WARMERS, BRAS, LEGGINGS AND ATHLETIC TIGHTS, LEOTARDS, ROBES, HEADBANDS, WRISTBANDS, UNITARDS, AND KNIT FACE MASKS BEING HEADWEAR; HEADWEAR; FOOTWEAR;
FORVR MOOD	Aina, Jacquelyn	9190 West Olympic Boulevard, Suite 332 Los Angeles CA 90212	FOREVER MOOD;(Based on Use in Commerce) PILLOW CASES, PILLOW COVERS; (Based on Intent to Use) BED BLANKETS; BED COVERS; BED LINEN; BED SHEETS; BED THROWS; COMFORTERS; DUVET COVERS; DUVETS; QUILTS; SHAMS; SHEET SETS; THROWS; TOWEL SETS; TOWELS; WASHCLOTHS; BABY BLANKETS; BATH TOWELS; BEACH TOWELS; BLANKET THROWS;
	Where the owner name is not linked, that owner no longer owns the brand

Technical Examples

The present invention relates to androgen receptor targeting agents (ARTA) which demonstrate androgenic and anabolic activity, which are nonsteroidal ligands for the androgen receptor. The selective androgen receptor modulators (SARM) are useful for a) male contraception; b) treatment of a variety of hormone-related conditions, for example conditions associated with Androgen Decline in Aging Male (ADAM), such as fatigue, depression, decreased libido, sexual dysfunction, erectile dysfunction, hypogonadism, osteoporosis, hair loss, anemia, obesity, sarcopenia, osteopenia, osteoporosis, benign prostate hyperplasia, alterations in mood and cognition and prostate cancer; c) treatment of conditions associated with Androgen Decline in Female (ADIF), such as sexual dysfunction, decreased sexual libido, hypogonadism, sarcopenia, osteopenia, osteoporosis, alterations in cognition and mood, depression, anemia, hair loss, obesity, endometriosis, breast cancer, uterine cancer and ovarian cancer; d) treatment and/or prevention of chronic muscular wasting; e) decreasing the incidence of, halting or causing a regression of prostate cancer; f) oral androgen relacement and/or other clinical therpauetic and/or diagnostic areas.